Italian Study Says Espresso and Moka Pot May Reduce This Liver Disease
Daily Coffee News Staff| August 5, 2026 A new study among coffee drinkers in southern Italy found that people who drink espresso or moka pot brews on a daily basis were less likely to develop the liver disease known as MASLD. In the study, the protective benefit appeared to grow stronger with each cup, plateauing at 4-6 cups per day. Yet before going further, it should be noted that numerous studies over the past decade have associatedcoffee consumption of all kindswith potentially protective effects on liver health. Published March 19 in Frontiers in Nutrition, the Italian study examined 1,079 coffee-drinking adults for associations between daily Italian-style coffee consumption and metabolic dysfunction-associated steatotic liver disease, (MASLD). MASLD is defined as fat accumulation in the liver combined with at least one cardiometabolic risk factor, such as obesity, high blood sugar, high blood pressure or abnormal cholesterol levels, while excluding harmful levels of alcohol intake. “Given its cultural relevance and favorable metabolic profile, Italian-style coffee may be considered a functional food for MASLD prevention, with caution advised for sensitive populations,” the authors wrote. One cup per day was associated with roughly 52% lower odds of MASLD compared to less than one cup daily. Odds were 53% lower at two cups per day, 55% lower at three cups per day and 59% lower at 4-6 cups per day. All findings are from an adjusted model accounting for age, sex, BMI, diastolic blood pressure, daily energy intake, sugar in coffee, milk in coffee, smoking, adherence to a Mediterranean diet, education, spirits intake, HDL cholesterol, liver enzyme ratios and glycemic status. The study only included espresso and moka preparations, which are the dominant brewing styles in Italy. Unlike filtered or instant coffee, both methods use pressure-based extraction without paper filtration, retaining higher concentrations of fat-soluble compounds
Daily Coffee News Staff| August 5, 2026 A new study among coffee drinkers in southern Italy found that people who drink espresso or moka pot brews on a daily basis were less likely to develop the liver disease known as MASLD.
Tech news moves quickly enough that any single story is best read as one data point in a longer arc. The products change, the companies shuffle, but the underlying patterns — incentives, supply chains, regulatory lag — tend to repeat.
The most useful frame for reading coverage like this is to ask what would have to be true for the announcement to matter in a year. Most of the time, the honest answer is "not much." Occasionally, the answer is "everything," and those are the stories worth following up on.
We will keep tracking this one as it develops. If the details shift materially, we will update this piece rather than publish a follow-up that contradicts it.
